Rachel Yehuda, PhD, is exploring whether psychedelics can be a useful treatment for post-traumatic stress disorder (PTSD). Her journey began with a study on 3,4-methylenedioxy-methamphetamine (MDMA) in veterans and is expanding to investigate psilocybin.